Advertisement
MRK vs STE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRK is a Hold and STE is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MRK’s FA Score shows that 0 FA rating(s) are green whileSTE’s FA Score has 0 green FA rating(s).
- MRK’s FA Score: 0 green, 5 red.
- STE’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MRK’s TA Score shows that 6 TA indicator(s) are bullish while STE’s TA Score has 4 bullish TA indicator(s).
- MRK’s TA Score: 6 bullish, 3 bearish.
- STE’s TA Score: 4 bullish, 5 bearish.
Price Growth
MRK (@Pharmaceuticals: Major) experienced а +0.18% price change this week, while STE (@Medical Specialties) price change was -1.60% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.01%. For the same industry, the average monthly price growth was -0.04%, and the average quarterly price growth was +10.01%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.00%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was -1.40%.
Reported Earning Dates
MRK is expected to report earnings on Oct 30, 2025.
STE is expected to report earnings on Nov 10, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (+1.01% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Medical Specialties (-1.00% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| MRK | STE | MRK / STE | |
| Capitalization | 332B | 22.2B | 1,495% |
| EBITDA | 6.91B | 1.39B | 495% |
| Gain YTD | -16.518 | 11.875 | -139% |
| P/E Ratio | 935.64 | 38.85 | 2,409% |
| Revenue | 60.1B | 5.41B | 1,112% |
| Total Cash | 7.09B | 196M | 3,619% |
| Total Debt | 35.1B | 3.51B | 1,000% |
MRK | STE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 19 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 71 | 44 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 61 | 58 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MRK's Valuation (50) in the Pharmaceuticals Major industry is in the same range as STE (50) in the Medical Specialties industry. This means that MRK’s stock grew similarly to STE’s over the last 12 months.
STE's Profit vs Risk Rating (44) in the Medical Specialties industry is in the same range as MRK (71) in the Pharmaceuticals Major industry. This means that STE’s stock grew similarly to MRK’s over the last 12 months.
STE's SMR Rating (100) in the Medical Specialties industry is in the same range as MRK (100) in the Pharmaceuticals Major industry. This means that STE’s stock grew similarly to MRK’s over the last 12 months.
STE's Price Growth Rating (58) in the Medical Specialties industry is in the same range as MRK (61) in the Pharmaceuticals Major industry. This means that STE’s stock grew similarly to MRK’s over the last 12 months.
STE's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as MRK (100) in the Pharmaceuticals Major industry. This means that STE’s stock grew similarly to MRK’s over the last 12 months.
| MRK | STE | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 65% |
| Stochastic ODDS (%) | 1 day ago 55% | 1 day ago 66% |
| Momentum ODDS (%) | 1 day ago 41% | 1 day ago 61% |
| MACD ODDS (%) | 1 day ago 38% | N/A |
| TrendWeek ODDS (%) | 1 day ago 49% | 1 day ago 54% |
| TrendMonth ODDS (%) | 1 day ago 44% | 1 day ago 50% |
| Advances ODDS (%) | 6 days ago 48% | 15 days ago 57% |
| Declines ODDS (%) | 9 days ago 50% | 2 days ago 49% |
| BollingerBands ODDS (%) | 1 day ago 57% | 1 day ago 68% |
| Aroon ODDS (%) | 1 day ago 54% | 1 day ago 42% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMQQ | 41.40 | 0.81 | +1.99% |
| EMQQ The Emerging Markets Internet ETF | |||
| FFEM | 28.28 | 0.22 | +0.77% |
| Fidelity Fundamental Emerging Markets ETF | |||
| QRFT | 57.02 | -0.20 | -0.35% |
| QRAFT AI-Enhanced US Large Cap ETF | |||
| ACSI | 62.89 | -0.55 | -0.86% |
| American Customer Satisfaction ETF | |||
| XOP | 128.84 | -2.84 | -2.16% |
| SPDR® S&P Oil & Gas Explor & Prodtn ETF | |||
MRK and
Correlation & Price change
A.I.dvisor indicates that over the last year, MRK has been loosely correlated with PFE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then PFE could also see price increases.
| Ticker / NAME | Correlation To MRK | 1D Price Change % | ||
|---|---|---|---|---|
| MRK | 100% | -2.57% | ||
| PFE - MRK | 48% Loosely correlated | -2.92% | ||
| AZN - MRK | 44% Loosely correlated | -1.98% | ||
| BIIB - MRK | 43% Loosely correlated | -4.21% | ||
| ABBV - MRK | 43% Loosely correlated | -1.84% | ||
| AMGN - MRK | 40% Loosely correlated | -1.52% | ||
More | ||||